Ledger.Open graph →
SEC Form D · filed June 16, 2023

Avenzoar Pharmaceuticals, Inc

Offering
$3.0M
Sold
$900K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Los Angeles, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Shierley J. Widjaja · Los Angeles, CADirectorMark J. Chin · Los Angeles, CADirectorStephen J. Pandol · Los Angeles, CADirectorMouad J. Edderkaoui · Los Angeles, CADirectorTerrance J. Bruggeman · Los Angeles, CAExec · DirectorMark J. Chin · Los Angeles, CADirectorShierley J. Widjaja · Los Angeles, CADirectorStephen J. Pandol · Los Angeles, CADirectorMouad J. Edderkaoui · Los Angeles, CADirectorTerrance J. Bruggeman · Los Angeles, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗